EFFICACY AND SAFETY OF BUDESONIDE AS FIRST LINE TREATMENT IN PATIENTS WITH AUTOIMMUNE HEPATITIS: SPANISH MULTICENTER STUDY

被引：0

作者：

Diaz-Gonzalez, Alvaro ^{[1
,2
]}

Hernandez-Guerra, Manuel ^{[3
]}

Gomez, Elena ^{[4
]}

Sapena, Victor ^{[5
]}

Perez-Medrano, Indhira ^{[6
]}

Del Barrio, Maria ^{[7
]}

Escude, Laia ^{[8
]}

Riveiro Barciela, Mar ^{[9
]}

Barreira-Diaz, Ana ^{[9
]}

Soria, Anna ^{[10
]}

Molina, Esther ^{[11
]}

Ferre-Aracil, Carlos ^{[12
]}

El Hajra, Ismael ^{[12
]}

Arencibia, Ana C. ^{[13
]}

Morillas Cunill, Rosa M. ^{[14
]}

Gomez-Camarero, Judith ^{[15
]}

Conde, Isabel ^{[16
]}

Mateos, Beatriz ^{[17
]}

Horta, Diana ^{[18
]}

Estevez, Pamela ^{[19
]}

Lopez, Carmen ^{[20
]}

Navascues, Carmen A. ^{[21
]}

Zamora, Javier ^{[22
]}

Garcia-Retortillo, Montserrat ^{[23
]}

Fernandez, Ainhoa ^{[24
]}

Crespo Garcia, Javier ^{[25
]}

Carlota Londono, Maria ^{[26
]}

机构：

[1] Hosp Univ Marques De Valdecilla, Digest Dis Dept, Inst Invest Sanitaria Valdecilla, Santander, Spain

[2] Hosp Univ Marques De Valdecilla, Santander, Spain

[3] Univ Hosp Canary Isl, Dept Gastroenterol, San Cristobal Laguna, Spain

[4] Hosp Univ 12 Octubre, Digest Dis Dept, Madrid, Spain

[5] Hosp Clin Barcelona, IDIBAPS, Med Stat Core Facil, Barcelona, Spain

[6] Complejo Hosp Univ Pontevedra, Digest Dis Dept, Pontevedra, Spain

[7] Marques De Valdecilla Univ Hosp, Gastroenterol & Hepatol, Santander, Spain

[8] Hosp Clin Barcelona, Liver Unit, Barcelona, Spain

[9] Hosp Univ Vall Dhebron, Dept Internal Med, Liver Unit, Barcelona, Spain

[10] Univ Autonoma Barcelona, Parc Tauli Hosp Univ, I3PT, Liver Unit, Sabadell, Spain

[11] Complejo Hosp Univ Santiago, Digest Dis Dept, Santiago De Compostela, Spain

[12] Hosp Univ Puerta De Hierro Majadahonda, Digest Dis Dept, Madrid, Spain

[13] Hosp Univ Nuestra Senora Candelaria, Liver Unit, Santa Cruz De Tenerife, Spain

[14] Hosp Badalona Germans Trias & Pujol, Hepatol Unit, Barcelona, Spain

[15] Hosp Univ Burgos, Burgos, Spain

[16] Hosp Univ & Politecn La Fe, Inst Invest Sanitaria La Fe, Digest Dis Dept, Valencia, Spain

[17] HU Ramon y Cajal, Gastroenterol, Madrid, Spain

[18] Hosp Univ Mutua Terrassa, Digest Dis Dept, Terrassa, Spain

[19] Hosp Univ Alvaro Cunqueiro, Digest Dis Dept, Vigo, Spain

[20] Hosp Univ Josep Trueta, Digest Dis Dept, Girona, Spain

[21] Hosp Univ Cent Asturias, Liver Unit, Div Gastroenterol & Hepatol, Oviedo, Spain

[22] Hosp Univ Reina Sofia, Digest Dis Dept, Cordoba, Spain

[23] Hosp Del Mar, Serv Digest, Secc Hepatol, Barcelona, Spain

[24] Hosp Gen Univ Gregorio Maranon, Digest Dis Dept, Madrid, Spain

[25] Hosp Univ Marques De Valdecilla, Digest Dis Dept, Inst Invest Sanitaria Valdecilla, Santander, Spain

[26] Hosp Clin Barcelona, Liver Unit, Barcelona, Spain

来源：

HEPATOLOGY | 2021年 / 74卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1268

引用

页码：761A / 762A

页数：2

共 50 条

[1] Budesonide in the first line treatment of patients with autoimmune hepatitis
Olivas, Ignasi
Cobreros, Marina
Londono, Maria-Carlota
Diaz-Gonzalez, Alvaro
[J]. GASTROENTEROLOGIA Y HEPATOLOGIA, 2022, 45 (07): : 561 - 570
[2] Efficacy and Limitations of Budesonide as a Second-Line Treatment for Patients With Autoimmune Hepatitis
Peiseler, Moritz
Liebscher, Tina
Sebode, Marcial
Zenouzi, Roman
Hartl, Johannes
Ehlken, Hanno
Pannicke, Nadine
Weiler-Normann, Christina
Lohse, Ansgar W.
Schramm, Christoph
[J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (02) : 260 - +
[3] Safety and efficacy of budesonide during pregnancy in women with autoimmune hepatitis
Wiest, Isabella
Roig, Ana
Antoni, Christoph
Ebert, Matthias
Teufel, Andreas
[J]. JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2022, 31 (02) : 256 - 257
[4] Safety and Efficacy of Budesonide During Pregnancy in Women With Autoimmune Hepatitis
Rahim, Mussarat N.
Ran, Shaolu
Shah, Sital
Hughes, Sarah
Heneghan, Michael A.
[J]. HEPATOLOGY, 2021, 73 (06) : 2601 - 2606
[5] Budesonide as a first line therapy in autoimmune hepatitis: A systematic review
Ajwah, Ibrahim Mahmoud
Albalawi, Mohammed Abdullah
Alenazi, Bashayer Jazza
Alamri, Saif Mohammed
Qubays, Faris Essa
Ajwah, Abdullah Mahmoud
Alghamdi, Abdullah Saeed
Alanazi, Nader Awad
Asseri, Abdul Wahab Ali
Algamdi, Kholoud Abdullah
Alenezi, Solaiman Hosaian
Makai, Ahmad Jamil
Amer, Mohamed Omar
[J]. AUSTRALASIAN MEDICAL JOURNAL, 2020, 13 (06): : 207 - 212
[6] Budesonide in autoimmune hepatitis after relapse: A pilot study to evaluate efficacy and safety.
Czaja, AJ
Lindor, KD
[J]. GASTROENTEROLOGY, 2000, 118 (04) : A898 - A898
[7] TREATMENT OF AUTOIMMUNE HEPATITIS WITH BUDESONIDE
SCHULER, A
MOLLMANN, HW
MANNS, M
[J]. HEPATOLOGY, 1995, 22 (04) : 1525 - 1525
[8] Budesonide in the treatment of autoimmune hepatitis
Katherine Sole
[J]. Nature Clinical Practice Gastroenterology & Hepatology, 2006, 3 (1): : 8 - 8
[9] Budesonide for the Treatment of Autoimmune Hepatitis
Snider, Kenneth R.
Potter, Teresa G.
[J]. ANNALS OF PHARMACOTHERAPY, 2011, 45 (09) : 1144 - 1150
[10] Budesonide for the Treatment of Autoimmune Hepatitis
不详
[J]. GASTROENTEROLOGE, 2015, 10 (04): : 320 - 320

← 1 2 3 4 5 →